Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Fund Me, KC: ‘Scarlet Knight’ returns to inner city streets with a moral dilemma about abuse of power
Startland News is continuing its segment to highlight area entrepreneurs’ efforts to accelerate their businesses. This is an opportunity for entrepreneurs — like Juaquan Allen with his Scarlet Knight campaign — to share their crowdfunding stories to gain a little help from their supporters. Who are you? My name is Juaquan “Jay” Allen. I’m a…
Design by fire: Could a Kansas City company 3-D print the Notre Dame spire?
Beyond its status as the biggest in Kansas City, the impact of Dimensional Innovations’ new $2.2 million 3-D printer could reach globally — as the homegrown company considers ways it could help rebuild the historic spire atop the Notre Dame Cathedral, said Nate Borozinski. “This thing gives us an ability — and we think an…
Look inside: Fishtech Group opens its $10M+ Cyber Defense Center in Martin City
Fishtech Group is making a splash within the cyber security industry, showcasing its cloud-era capabilities in a new Cyber Defense Center that sits behind the gates of Fishtech’s sprawling Martin City campus, said Gary Fish. “I’ve been doing security since before it was cool,” said Fish, founder and CEO of Fishtech, as well as an…
Elite investors at exclusive CEO retreat: Don’t waste time; sell us on your billion-dollar idea
Trying to land the backing of a venture capital firm? Throw your pitch deck out the window, Chris Olsen advised a select group of Kansas City CEOs. “A lot of times founders will come and give us their pitch and they’ll start going through it and [they’re telling us] they’re profitable in 18-months. And we’ll…